Clinical Channel Icon 

As the biopharma industry faces the challenge of increasing costs and high probability of clinical failures, more emphasis is placed on strategies to de-risk and innovate drug development. The wide availability of genomic technologies acts as the prime driver of innovation in the clinical development field. The Clinical Channel will explore strategies, tools and technologies to improve translation and clinical development.

Epigenomics in Disease


Genomic Technologies for Patient Stratification


Translational to Clinical R&D


Clinical Sequencing


Technology-Driven Oncology Clinical Development

 

You may also be interested in:

Symposia:

New Frontiers in Gene Editing- NEW

Circulating Cell-Free DNA

Genomics in Medicine

Genomics & Sequencing Data Integration Analysis and Visualization

Clinical Cancer Immunotherapy - NEW


Short Courses:

Translating CTCs to Clinical Use

Latest Advances in Molecular Pathology

Sequencing 101

PCR Part I: Primer Design for PCR Experiments

Knowing Your NGS Analysis Upstream

Regulatory Compliance in Molecular Diagnostics

Isolation and Characterization of Cancer Stem Cells

Using Preclinical Models in Oncology

Best Practices in Personalized and Translational Medicine

NGS for Infectious Disease Diagnostics

 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

 

2015 MMTC Final Agenda 

Premier Sponsors:

Elsevier 


Jackson Laboratory - small logo 

Leica Biosystems 
 

 NanoString2   

 

Silicon Biosystems 

 

Singulex 

Thomson Reuters-Large 






Local Partners:

BayBio 


biocube 


Cabs 

City of SSF